Splicing Factor Mutations Predict Poor Prognosis in Patients With De Novo Acute Myeloid Leukemia

Oncotarget - United States
doi 10.18632/oncotarget.7000
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Low Expression of Circulating microRNA-328 Is Associated With Poor Prognosis in Patients With Acute Myeloid Leukemia

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2015English

Aberrant RNA Splicing and Mutations in Spliceosome Complex in Acute Myeloid Leukemia

Stem Cell Investigation
2017English

Human BDH2, an Anti-Apoptosis Factor, Is a Novel Poor Prognostic Factor for De Novo Cytogenetically Normal Acute Myeloid Leukemia

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2013English

Anthracycline Versus Non-Anthracycline Induction Regimens in Patients With De Novo Acute Myeloid Leukemia

Middle East Journal of Internal Medicine
2017English

Downregulated Stromal Antigen 2 Expression in De Novo Acute Myeloid Leukemia Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Upregulation of Mir-99a Is Associated With Poor Prognosis of Acute Myeloid Leukemia and Promotes Myeloid Leukemia Cell Expansion

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Acute Myeloid Leukemia With NPM1 Somatic Mutations

2020English

Prognosis of Patients With a Second Relapse of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Association Between Increased Mutation Rates in DNMT3Α and FLT3‑ITD and Poor Prognosis of Patients With Acute Myeloid Leukemia

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy